share_log

麦澜德(688273.SH)：公司新产品目前已有部分医院完成销售

Meilande (688273.SH): Some hospitals have completed sales of the company's new products.

Gelonghui Finance ·  Jun 4 04:06

On June 4th, Gelunhui announced that Mailande (688273.SH) stated in the company's 2023 and 2024 first quarter performance and cash dividend description meeting that the company launched a self-developed "Magnetic Electric Thermal Imaging • Zhirong PI-ONE" pelvic floor intelligent diagnosis and treatment system in March this year, with leading technology in the industry. The product integrates pelvic floor structure and functional information, comprehensively evaluates the pelvic floor status, and uses big data intelligent algorithms to assist physicians in matching individualized magnetic, electric, and thermal treatment plans for patients. It solves three major problems that have existed for a long time: "difficult diagnosis", "many treatment methods, difficult to choose treatment methods and plans", and "difficulties in collecting, summarizing, and using scientific research and academic data", which improves the accuracy and efficiency of medical services, reduces the learning costs of clinical doctors, brings better medical experience to patients, and improves treatment efficiency. Currently, the new product is actively promoting according to the established sales policy. Some hospitals have completed sales.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment